5 results
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... infection Episode #Pharmacology ... #Management #CDiff ... CDifficile #IDSA2017 #Adjunct ... #Antibiotics
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Parenteral Antimicrobial ... Parenteral #IV #Antibiotics ... Osteomyelitis #management ... #treatment #pharmacology ... #idsa
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... fluoroquinolone #IDSA ... Acquired #Pneumonia #Antibiotics ... #Management #Guidelines ... #pharmacology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... post-ABx, but can ... (IDSA 2021): ... mg/kg IV x 1 - Adjunct ... ciab549 #CDI #Cdiff
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Enteric Illness: • Antimicrobial ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology